Exosens, a high-tech company specializing in mission- and performance-critical amplification, detection, and imaging technologies, has secured a €140 million financing facility with the European Investment Bank (“EIB”). The facility will support the Group’s research, development, and innovation activities, as well as selected industrial investments serving European defense, surveillance, and industrial end markets, which benefit from strong structural growth drivers.